The association between Metabolic Syndrome and serum levels of lipid peroxidation and interleukin-6 in Gorgan

Background: There are limited studies on the relationship between inflammatory marker such as IL-6 and lipid peroxidation and metabolic syndrome. Objective: The aim of present study was to assess IL-6 and lipid peroxidation in subjects with and without the metabolic syndrome and their association with metabolic syndrome components. Methods: Age and gender matched 40 subjects with metabolic syndrome and 40 control groups took part in this study. Results: The mean malondialdehyde level was significantly higher in overweight and obese subjects with metabolic syndrome than control groups (P. <. 0.05). The mean level of IL-6 in men and the mean level of malondialdehyde in women with metabolic syndrome was significantly higher than control groups (p <. 0.05). There were significant positive correlation between malondialdehyde and fasting blood glucose, triglyceride and systolic blood pressure (p <. 0.05). Conclusions: Our results suggest that higher levels of IL-6 and malondialdehyde may cause insulin resistance and metabolic disorders in all subjects with metabolic syndrome. Malondialdehyde level shows strong association with some metabolic syndrome components. This means the greater risk of metabolic syndrome. © 2015

Prevalence of metabolic syndrome in baluch women in Chabahar

Epidemiological studies have shown the importance of the metabolic syndrome. With estimation of the metabolic syndrome, it may predict cardiovascular disease, sudden death and the presence of some other cardiovascular risk factors. The aim of this study was to assess the metabolic syndrome among Baluch women. Our study consisted of 120 Baluch women. Baseline data of Baluch women, prevalence of metabolic syndrome and its components and distribution of body mass index were determined. The mean Body Mass Index (BMI), waist circumference, systolic blood pressure, triglyceride, High Density Lipoprotein-Cholesterol (HDL-Chol.) and fasting blood glucose levels were significantly higher in the subjects with metabolic syndrome. The prevalence of HDL-cholesterol, high triglyceride, high fasting glucose levels, high waist circumference and high blood pressure were shown to be 33.3, 20.8, 12.5, 11.8 and 2.5, respectively. HDL-cholesterol (33.3) and high triglyceride levels (20.8) were the most frequent characteristics of metabolic components. The prevalence of subject with normal weight, overweight and obese BMIs were 77.5, 15 and 7.5, respectively. About 9.17, 4.17 and 4.17 of Baluch women had three, four and five criteria of metabolic syndrome components, respectively. This study reveals that there is a significant difference in the metabolic syndrome components in patients with and without metabolic syndrome. The prevalence of HDL-cholesterol and high triglyceride in Baluch women was highest. Definition of metabolic syndrome may help physicians to estimate, decrease and prevent coronary heart disease and cardiovascular morbidity and mortality in subjects with metabolic syndrome. © 2015 Asian Network for Scientific Information

The Metabolic Syndrome among Postmenopausal Women in Gorgan

In this study, we aimed to assess levels of serum 25-hydroxyvitamin D in relation to metabolic syndrome among postmenopausal women in Gorgan. The study group included 100 postmenopausal women who were referred to the different Health Centers in Gorgan. Body mass index, waist circumference, Hip, waist to hip ratio, diastolic blood pressure, triglyceride, fasting blood glucose and 25-hydroxyvitamin D levels were significantly higher in postmenopausal women with metabolic syndrome, but HDL-cholesterol was lower. Prevalence of the metabolic syndrome was 31%. There were significant differences in 25-hydroxy vitamin D of postmenopausal women with and without vitamin D deficiency. Prevalence of the vitamin D deficiency in postmenopausal women was 30%. There were significant differences in 25-hydroxy vitamin D of postmenopausal women with and without vitamin D deficiency who had metabolic syndrome. Our results show that postmenopausal status might be a predictor of metabolic syndrome in this area. Our findings suggested that vitamin D levels have no association with metabolic syndrome. There were no significant differences in vitamin D levels in postmenopausal women with and without metabolic syndrome. Vitamin D deficiency is not associated with the metabolic syndrome

The metabolic syndrome in type 2 diabetic subjects in Gorgan, Iran

Objective: To assess the prevalence of the metabolic syndrome in subjects diagnosed with Type 2 diabetes in Gorgan, Iran.Methods: Data were collected from 200 subjects with Type 2 diabetes mellitus and they were categorized aswith or without the metabolic syndrome. Metabolic syndrome was diagnosed using Adult Treatment Panel-III(ATP-III) guidelines.Results: The overall metabolic syndrome prevalence was 51.50%. The mean age of all the subjects was53.65±9.50 years. There were 122 females and 78 males of whom 65 females and 38 males had the metabolic syndrome. The mean uration of diabetes was 7.70±1.29 years. Mean triglycerides were 185.15±56.63 mg/dl,and fasting blood glucose 153 ±19.6 mg/dl. These levels were significantly higher in the subjects with type-2diabetes with metabolic syndrome, but the mean HDL-cholesterol was 37.96±5.09 mg/dl and this was lower (p<0.001). Female and male subjects with metabolic syndrome had significantly longer (except HDL-cholesterol)duration of diabetes, higher Triglyceride, and fasting blood glucose levels (p < 0.001, p < 0.05).Conclusion: This study showed a high prevalence of the metabolic syndrome in subjects with type 2 diabetes. Females were more affected than males

The Role of Higher Protein Diets in the Regulation of Mood and Sleep in Patients with Metabolic Syndrome

Metabolic Syndrome is becoming a more prevalent health issue within the United States, currently affecting 22% of adults (Capuron et al., 2008). Several factors contribute to the diagnosis of Metabolic Syndrome, including obesity, high levels of triglycerides, elevated blood pressure, and low high-density lipoprotein cholesterol. Metabolic Syndrome puts those who have it at an increased risk for numerous diseases, such as type 2 diabetes, cardiovascular disease, and cancer (Jennings et al., 2007). Several studies have shown that Metabolic Syndrome plays a negative role in sleep and mood of those with the disease. Individuals with Metabolic Syndrome often have poor sleep quality, which could contribute to worsening of the risk factors associated with the disease (Hung et. al 2013). Metabolic Syndrome has also been linked to obstructive sleep apnea and is prevalent in those with the disease (Parish et al., 2007). There is also evidence that short sleep duration and poor sleep quality are associated with obesity, one of the risk factors for Metabolic Syndrome (Jennings et al., 2007)

Age related metabolic syndrome among hemodialysis patients in Gorgan, Iran

People with metabolic syndrome are at high risk for developing cardiovascular disease. The present study aimed to determine the age related metabolic syndrome of hemodialysis patients. The biochemical parameters and demographic information were registered. The prevalence of metabolic syndrome was significantly high in ages 50-59 and 60-69 years in hemodialysis patients when compared with other age groups (P< 0.05). There was elevated frequency of metabolic syndrome from age 50-59 and 40-49 years in male and female hemodialysis patients, respectively. The frequency of metabolic syndrome in female subjects (65.27%) was higher than male (47.14%, P<0.05). The prevalence of metabolic syndrome was high in ages 50-59 years in males and females. There was a significant difference in hemodialysis patients with metabolic syndrome in ages 50-59 years in males and from ages 40-49, 50-59 and 60-69 years in females (P< 0.05). Our results show that 25.71%, 18.57% and 2.86% males and 36.11%, 20.83% and 8.33% females had three, four and five criteria for metabolic syndrome, respectively. The results of this study showed that females patients were more affected than males. This may depended on the specific lifestyle alterations among females and males patients in this area. Marjani et al

Prevalence of the metabolic syndrome in Chinese adolescents

Since national figures on the occurrence of metabolic syndrome among Chinese adolescents are lacking, this study aims to estimate its prevalence and distribution among Chinese youngsters. The 2002 China National Nutrition and Health Survey is a nationally representative cross-sectional study. Applying the criteria for US adolescents, we estimated the prevalence of metabolic syndrome among 2761 adolescents aged 15 to 19 years. The prevalence of metabolic syndrome among Chinese adolescents overall was 3·7% (10% in US adolescents). It was 35·2 %, 23·4% and 2·3% among adolescents who were overweight (BMI $95th percentile), at risk of overweight (BMI between 85th and 95th percentile) and normal weight (BMI below the 85th percentile), respectively. Urban boys had the highest rate (5·8$85th percentile and one or two parent(s) with metabolic syndrome, the prevalence was 46·4 %. A total of 96% of overweight adolescents had at least one and 74·1% overweight adolescents had at least two abnormalities of metabolic syndrome. Based on these figures, it is estimated that more than three million Chinese adolescents have metabolic syndrome. Both overweight and metabolic syndrome prevalence among adolescents are still relatively low in China, but the prevalence of metabolic syndrome among Chinese overweight adolescents is similar to those living in the USA

The prevalence of metabolic syndrome amongst patients with severe mental illness in the community in Hong Kong--a cross sectional study

Background: Patients with severe mental illness are at increased risk of developing metabolic disorders. The risk of metabolic syndrome in the Hong Kong general population is lower than that observed in western countries; however the prevalence of metabolic syndrome in patients with severe mental illness in Hong Kong is unknown. Method: This cross-sectional study aimed to estimate the prevalence of metabolic syndrome in patients with severe mental illness in Hong Kong and to identify the relationships between metabolic syndrome and socio-demographic, clinical and lifestyle factors. Results: A total of 139 patients with a diagnosis of severe mental illness participated in the study. The unadjusted prevalence of metabolic syndrome was 35%. The relative risk of metabolic syndrome in comparison with the general Hong Kong population was 2.008 (95% CI 1.59-2.53, p < 0.001). In a logistic regression model sleep disruption and being prescribed first generation antipsychotics were significantly associated with the syndrome, whilst eating less than 3 portions of fruit/vegetables per day and being married were weakly associated. Conclusion The results demonstrate that metabolic syndrome is highly prevalent and that physical health inequalities in patients with severe mental illness in Hong Kong are similar to those observed in western countries. The results provide sufficient evidence to support the need for intervention studies in this setting and reinforce the requirement to conduct regular physical health checks for all patients with severe mental illness

Body mass index dependent metabolic syndrome in severe mental illness patients

The aim of this study was to evaluate the body mass index dependent metabolic syndrome in severe mental illness patients in Gorgan. A total of 267 severe mental illness patients took part in this study. The prevalence of metabolic syndrome in severe mental illness patients in different body mass index were 6.67, 24.09 and 53.06. There were significant differences in the mean of waist circumference, HDL-cholesterol, triglyceride and fasting blood glucose in subjects with metabolic syndrome in different body mass index when compared with subjects without metabolic syndrome (p<0.05). The prevalence of high fasting glucose, low high density lipoprotein-cholesterol, high triglyceride levels, high waist circumference and high blood pressure were 14.23, 38.57, 41.57, 32.96 and 5.24, respectively. It shows that high triglyceride levels (41.57) and Low HDL-cholesterol levels (38.57) were the most frequent characteristics in comparison to other metabolic components. Our results show that, 26.96, 31.08, 21.35, 15.35 and 5.25 of subjects had zero, one, two, three and four criteria for metabolic syndrome, respectively. These results show that the prevalence of metabolic syndrome in severe mental illness patients in Gorgan is increased with elevated body mass index. The results of this study suggest that mental illness patients are at risk of metabolic syndrome, when the rate of body mass index increases. Risk factors such as high triglyceride level and low HDL-cholesterol may play an important role in the occurrence of metabolic syndrome in severe mental illness patients. © 2015, Asian Network for Scientific Information. All rights reserved

The effect of 12 weeks Anethum graveolens (dill) on metabolic markers in patients with metabolic syndrome; A randomized double blind controlled trial

Background: The clustering of metabolic abnormalities defined as metabolic syndrome is now both a public health and a clinical problem .While interest in herbal medicine has greatly increased, lack of human evidence to support efficacies shown in animals does exist. This clinical trial study designed to investigate whether herbal medicine, Anethum graveolens (dill) extract, could improve metabolic components in patients with metabolic syndrome. Methods: A double-blind, randomized, placebo-controlled trial using a parallel design was conducted. 24 subjects who had metabolic syndrome diagnostic criteria (update of ATP III) were randomly assigned to either dill extract (n = 12) or placebo (n = 12) for 3 months. Results: Across lipid component of metabolic syndrome, no significant differences in triglyceride (TG) concentration and high density lipoprotein cholesterol were seen between the two groups. However TG improved significantly from baseline (257.0 vs. 201.5p = 0.01) with dill treatment but such a significant effect was not observed in placebo group. Moreover, no significant differences in waist circumference, blood pressure and fasting blood sugar were seen between two groups after 3 months follow up period. Conclusion: In this small clinical trial in patients with metabolic syndrome, 12 weeks of dill extract treatment had a beneficial effect in terms of reducing TG from baseline. However dill treatment was not associated with a significant improvement in metabolic syndrome related markers compared to control group. Larger studies might be required to prove the efficacy and safety of long-Term administration of dill to resolve metabolic syndrome components. © 2012 Mansouri et al.; licensee BioMed Central Ltd